Please login to the form below

Not currently logged in
Email:
Password:

Merck & Co’s Jürgen Polifka joins Cardiome

Will lead commercialisation in Europe of atrial fibrillation treatment Brinavess

Jürgen Polifka has left his role at Merck and Co to join Canada-based biopharma Cardiome as general manager, sales and marketing Europe.

Polifka was most recently regional marketing leader hospital care at Merck for a portfolio of products, including atrial fibrillation treatment Brinavess (vernakalant), which Cardiome is due to assume commercialisation responsibility for in Europe.

In total, Polifka spent more than 16 years at Merck, serving in several senior roles, such as product manager, marketing and sales manager, director hospital and specialty products and brand leader. During this time, he covered both infectious disease and cardiovascular care at different stages.

"We are extremely pleased to have Dr Polifka join Cardiome at such a critical time in its history," said Karim Lalji, Cardiome's chief commercial officer.

"His personal experience with Brinavess at MSD and deep understanding of the European hospital and cardiovascular markets will be invaluable as Cardiome assumes commercialisation responsibility for Brinavess in Europe."

9th April 2013

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

A snapshot of… Exscientia
...
Patients are ready for virtual clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...
Keep your audiences close
How getting up close and personal with target audiences can fuel creativity...

Infographics